Cefozopran
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.107.680 |
| Chemical and physical data | |
| Formula | C19H17N9O5S2 |
| Molar mass | 515.52 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Cefozopran (INN) is a fourth-generation cephalosporin.[1]
Spectrum of bacterial susceptibility and resistance
Most of the strains of Stenotrophomonas maltophilia have developed resistance toward cefozopran.[2]
References
- ^ Chang XM (December 1996). "Chapter 34: Market to Market". In Bristol JA (ed.). Annual Reports in Medicinal Chemistry. Vol. 31. San Diego, Calif.: Academic Press. p. 339. ISBN 978-0-08-058375-4.
- ^ "Cefozopran Susceptibility and Resistance Data" (PDF). Retrieved 23 July 2013.
